Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.56 USD | +0.60% | -4.25% | +69.19% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+69.19% | 1.3B | |
+38.53% | 727B | |
+30.57% | 592B | |
-7.74% | 347B | |
+15.48% | 319B | |
-0.41% | 274B | |
+12.55% | 238B | |
+6.65% | 204B | |
-6.09% | 203B | |
-3.39% | 160B |
- Stock Market
- Equities
- TARS Stock
- News Tarsus Pharmaceuticals, Inc.
- Tarsus Completes Enrollment for Phase 3 Trial of TP-03 to Treat Demodex Blepharitis; Secures $175 Million Credit Facility